Ken Fisher’s Precigen PGEN Stock Holding History

Ken Fisher’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,800	Closed	-$29.2K	–	1033
2023 Q4	$29.2K	Buy	+21,800	New	+$25.6K	﹤0.01%	975

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ken Fisher's PGEN Position: Q1 2024 in Review

Ken Fisher sold out of Precigen (PGEN) in Q1 2024, closing a stake of 21,800 shares — an estimated $29.2K sold.

Ken Fisher first reported a position in PGEN in Q4 2023 and held it in 1 quarter. The position peaked at $29.2K in Q4 2023. 130 funds tracked by Wall St. Rank hold PGEN as of Q1 2024.

Ken Fisher reported no remaining Precigen position as of Q1 2024 after selling out during the quarter.
Ken Fisher sold 21,800 Precigen shares in Q1 2024, an estimated $29.2K.
Ken Fisher first reported a position in Precigen in Q4 2023 and held it in 1 quarter.
Ken Fisher's Precigen position peaked at $29.2K in Q4 2023.
130 funds tracked by Wall St. Rank held Precigen as of Q1 2024.

Based on Fisher Asset Management's 13F filing for Q1 2024, filed 9 May 2024.